# Multi-centre Study to Assess the Efficacy and Safety of AZD5423 in COPD Patients on a Background Therapy of Formoterol

> **NCT01555099** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 353 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** AZD5423
- **DRUG:** Budesonide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01555099
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 353 (ACTUAL)
- **Last updated:** 2013-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01555099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01555099, "Multi-centre Study to Assess the Efficacy and Safety of AZD5423 in COPD Patients on a Background Therapy of Formoterol". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01555099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*